Engineered “mini livers” could be injected as an alternative to transplantation
Source:
mitTechReview
June 23, 2026 · 14:00
A technology developed by Professor Sangeeta Bhatia, SM ’93, PhD ’97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one. The liver is involved in regulating blood clotting, removing bacteria from the bloodstream, metabolizing drugs,…
The original article opens on the publisher's website.
More from Automotive
View topic →Larry Page’s flying car company Pivotal loses its CEO
techcrunch
Sep 1, 2026 · 16:59
SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading
coinDesk
Sep 1, 2026 · 16:55
The Range Rover Electric: Specs, Price, Availability
wired
Sep 1, 2026 · 16:01
North Carolina Rep. Chuck Edwards is formally censured over harassment allegations
nprNews
Sep 1, 2026 · 15:18
AfterQuery reportedly becomes Y Combinator’s fastest-ever unicorn, now valued at $3.2B
techcrunch
Sep 1, 2026 · 15:08